首页 > 最新文献

Clinical Obesity最新文献

英文 中文
Estimating the association and timing of occurrence between obesity and related comorbidity outcomes in a real-world setting: A cohort study in the United States 在现实世界中估计肥胖和相关合并症结果之间的关联和发生时间:美国的一项队列研究
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-06-04 DOI: 10.1111/cob.70026
Firas Dabbous, Jigish Bhavsar, Jayashri Desai, Anthony Fabricatore, Bríain Ó. Hartaigh, Wojciech Michalak, Sariya Udayachalerm, Cynthia Saiontz-Martinez, Zhenxiang Zhao, Fatima Cody Stanford

To understand the prevalence, incidence and sequence of obesity-related comorbidities (ORCs) among people with obesity compared with those with a normal body mass index (BMI). People with obesity (BMI ≥30 kg/m2) and normal BMI (BMI 18.5 to <25 kg/m2) were matched 1:1 using a large United States claims-linked electronic health record database. The index date was the date of the first qualifying BMI. Prevalence was assessed at baseline (12 months pre-index date); incidence and sequence of new ORCs were assessed during follow-up. Each cohort included 57 978 people. At least 1 ORC was present at baseline in 61.1% and 49.6% of the obesity and normal BMI cohorts, respectively. During follow-up (median 61 months) event rates per 1000 person-years of new ORCs were higher in the obesity cohort than the normal BMI cohort (572 vs. 378, respectively). In both cohorts, musculoskeletal pain was the most frequent new ORC, followed by dyslipidemia and hypertension. Median times to the first, second and third new ORC were shorter in the obesity cohort compared with the normal BMI cohort by 0.67, 0.81 and 0.66 years, respectively. People with obesity had a higher prevalence and incidence, and accelerated onset of ORCs compared with those with normal BMI.

了解肥胖人群与正常体重指数(BMI)人群中肥胖相关合并症(ORCs)的患病率、发病率和顺序。肥胖(BMI≥30 kg/m2)和正常BMI (BMI 18.5至2)的人使用大型美国索赔相关电子健康记录数据库进行1:1匹配。索引日期是第一个合格BMI的日期。在基线(指数前12个月)评估患病率;随访期间评估新发ORCs的发生率和顺序。每个队列包括57 978人。在肥胖组和正常BMI组中,分别有61.1%和49.6%的人在基线时存在至少1个ORC。在随访期间(中位61个月),肥胖组每1000人年新发ORCs的发生率高于正常BMI组(分别为572 vs 378)。在这两个队列中,肌肉骨骼疼痛是最常见的新ORC,其次是血脂异常和高血压。与正常BMI组相比,肥胖组到第一、第二和第三个新ORC的中位时间分别短0.67、0.81和0.66年。与BMI正常的人群相比,肥胖人群的患病率和发病率更高,ORCs的发病速度也更快。
{"title":"Estimating the association and timing of occurrence between obesity and related comorbidity outcomes in a real-world setting: A cohort study in the United States","authors":"Firas Dabbous,&nbsp;Jigish Bhavsar,&nbsp;Jayashri Desai,&nbsp;Anthony Fabricatore,&nbsp;Bríain Ó. Hartaigh,&nbsp;Wojciech Michalak,&nbsp;Sariya Udayachalerm,&nbsp;Cynthia Saiontz-Martinez,&nbsp;Zhenxiang Zhao,&nbsp;Fatima Cody Stanford","doi":"10.1111/cob.70026","DOIUrl":"10.1111/cob.70026","url":null,"abstract":"<p>To understand the prevalence, incidence and sequence of obesity-related comorbidities (ORCs) among people with obesity compared with those with a normal body mass index (BMI). People with obesity (BMI ≥30 kg/m<sup>2</sup>) and normal BMI (BMI 18.5 to &lt;25 kg/m<sup>2</sup>) were matched 1:1 using a large United States claims-linked electronic health record database. The index date was the date of the first qualifying BMI. Prevalence was assessed at baseline (12 months pre-index date); incidence and sequence of new ORCs were assessed during follow-up. Each cohort included 57 978 people. At least 1 ORC was present at baseline in 61.1% and 49.6% of the obesity and normal BMI cohorts, respectively. During follow-up (median 61 months) event rates per 1000 person-years of new ORCs were higher in the obesity cohort than the normal BMI cohort (572 vs. 378, respectively). In both cohorts, musculoskeletal pain was the most frequent new ORC, followed by dyslipidemia and hypertension. Median times to the first, second and third new ORC were shorter in the obesity cohort compared with the normal BMI cohort by 0.67, 0.81 and 0.66 years, respectively. People with obesity had a higher prevalence and incidence, and accelerated onset of ORCs compared with those with normal BMI.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144215063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of weight on daily activities questionnaire in patients with overweight or obesity: Psychometric evaluation using data from the OASIS 1 trial 体重对超重或肥胖患者日常活动问卷的影响:使用OASIS 1试验数据的心理测量学评估
IF 2.2 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-06-01 DOI: 10.1111/cob.70015
Lisa von Huth Smith, Diane Whalley, Stuart Yarr, Jonathan Comins, Sheri E. Fehnel

The Impact of Weight on Daily Activities Questionnaire (IWDAQ) is a patient-reported outcome measure that uses a novel, adaptive design to assess the limitations in daily activities that are most important to individuals attempting to lose weight. During the first round of completing the IWDAQ, respondents are presented with 18 everyday activities that can be limited by excess weight and asked to choose the three activities they would most like to see improve with weight loss. They are then asked to rate the degree of limitation they experience with these three activities at baseline and at follow-up assessments. Using data from a weight-management clinical trial (OASIS 1, NCT05035095), we evaluated the IWDAQ's measurement properties, determined optimal scoring, and estimated thresholds of meaningful within-patient change. Our analyses demonstrated that the IWDAQ Composite Score offers a reliable and valid personalized measure of limitations in daily activities due to excess weight. The adaptive design of the IWDAQ ensures the patient-centricity of the measure, thereby complementing existing measures of functioning in the context of weight-management clinical trials. Evaluations using data from additional studies would be valuable in extending the psychometric evidence for the IWDAQ.

体重对日常活动的影响问卷(IWDAQ)是一种患者报告的结果测量方法,它使用一种新颖的适应性设计来评估日常活动的局限性,这对试图减肥的个人来说是最重要的。在完成IWDAQ问卷的第一轮中,调查对象会被告知18项可能因体重过重而受到限制的日常活动,并被要求选择他们最希望看到体重减轻而改善的三项活动。然后要求他们在基线和后续评估中对这三种活动的限制程度进行评分。使用来自体重管理临床试验(OASIS 1, NCT05035095)的数据,我们评估了IWDAQ的测量特性,确定了最佳评分,并估计了患者内部有意义变化的阈值。我们的分析表明,IWDAQ综合得分提供了一个可靠的和有效的个性化的措施,在日常活动的限制,由于超重。IWDAQ的自适应设计确保了测量以患者为中心,从而补充了体重管理临床试验中现有的功能测量。利用来自其他研究的数据进行评价,对于扩大IWDAQ的心理测量证据将是有价值的。
{"title":"Impact of weight on daily activities questionnaire in patients with overweight or obesity: Psychometric evaluation using data from the OASIS 1 trial","authors":"Lisa von Huth Smith,&nbsp;Diane Whalley,&nbsp;Stuart Yarr,&nbsp;Jonathan Comins,&nbsp;Sheri E. Fehnel","doi":"10.1111/cob.70015","DOIUrl":"10.1111/cob.70015","url":null,"abstract":"<p>The Impact of Weight on Daily Activities Questionnaire (IWDAQ) is a patient-reported outcome measure that uses a novel, adaptive design to assess the limitations in daily activities that are most important to individuals attempting to lose weight. During the first round of completing the IWDAQ, respondents are presented with 18 everyday activities that can be limited by excess weight and asked to choose the three activities they would most like to see improve with weight loss. They are then asked to rate the degree of limitation they experience with these three activities at baseline and at follow-up assessments. Using data from a weight-management clinical trial (OASIS 1, NCT05035095), we evaluated the IWDAQ's measurement properties, determined optimal scoring, and estimated thresholds of meaningful within-patient change. Our analyses demonstrated that the IWDAQ Composite Score offers a reliable and valid personalized measure of limitations in daily activities due to excess weight. The adaptive design of the IWDAQ ensures the patient-centricity of the measure, thereby complementing existing measures of functioning in the context of weight-management clinical trials. Evaluations using data from additional studies would be valuable in extending the psychometric evidence for the IWDAQ.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 4","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144198409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Managing the New Wave of Weight Loss Medication in General Practice: A Qualitative Study” 更正“在全科医学中管理新一波减肥药:一项定性研究”。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-26 DOI: 10.1111/cob.70028

Andreassen P, Jensen SD, Bruun JM, et al. Managing the new wave of weight loss medication in general practice: a qualitative study. Clin Obes. 2024;14(3):e12666. doi:10.1111/cob.12666

The equal authorship designation was missing from this article at the time of publication. Pernille Andreassen and Sissel Due Jensen contributed equally to this article.

We apologize for the error.

Andreassen P, Jensen SD, Bruun JM等。在一般实践中管理减肥药物的新浪潮:一项定性研究。中国生物医学工程学报,2014;14(3):12666。doi: 10.1111 /棒子。12666在发表时,这篇文章缺少相同的作者署名。Pernille Andreassen和Sissel Due Jensen对本文也有贡献。我们为这个错误道歉。
{"title":"Correction to “Managing the New Wave of Weight Loss Medication in General Practice: A Qualitative Study”","authors":"","doi":"10.1111/cob.70028","DOIUrl":"10.1111/cob.70028","url":null,"abstract":"<p>Andreassen P, Jensen SD, Bruun JM, et al. Managing the new wave of weight loss medication in general practice: a qualitative study. <i>Clin Obes</i>. 2024;14(3):e12666. doi:10.1111/cob.12666</p><p><i>The equal authorship designation was missing from this article at the time of publication. Pernille Andreassen and Sissel Due Jensen contributed equally to this article</i>.</p><p><i>We apologize for the error</i>.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144148945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The tighter the stoma, the greater the loss: A narrower gastrojejunostomy is more beneficial for weight loss following roux-en-Y gastric bypass 造口越紧,减重越大:狭窄的胃空肠造口对roux-en-Y胃旁路术后的减重更有利。
IF 2.2 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-18 DOI: 10.1111/cob.70013
Keivan Kalali, Tooraj Zandbaf, Ali Esparham, Soheil Ahmadyar, Ali Jangjoo, Mojtaba Meshkat, Mohammad Ebrahim Kalantari, Mohammad Javad Ghamari, Alireza Rezapanah, Amin Dalili

The optimal size of Gastrojejunostomy (GJ) in Laparoscopic Roux-EnY Gastric Bypass (LRYGB) for a- preferential weight loss is still unknown. This study aimed to investigate the influence of linear-stapled GJ size in long-term LRYGB weight reduction results. We performed a retrospective analysis of 100 patients who underwent LRYGB surgery between January and July 2021. The patients were divided into two 50-patient groups based on the size of their linear-stapled GJ, either 30 or 45 mm. Their weight loss was observed and compared on day 15, and the following appointments were 1, 3, 6, 9, 12, 18, and 24 months after surgery. After 24 months, the 30-mm group reduced their BMI by an average of 19.23, compared with the 16.43 kg/m2 of the 45-mm group (p < .001). Overall, repeated measures ANOVA showed a beneficial weight loss pattern for the 30-mm group in all four categories (weight, BMI, EWL, and TWL). Upon adjusting for age, biliopancreatic length, alimentary length, sex, history of diabetes, and a history of hypertension in repeated measures ANOVA, this difference remained significantly in favour of the 30-mm GJ. Based on the results of this study, performing a gastrojejunostomy with a 30-mm stapler compared to a 45-mm stapler increases weight loss in LRYGB patients.

在腹腔镜Roux-EnY胃旁路术(LRYGB)中,胃空肠造口术(GJ)的最佳尺寸仍不清楚。本研究旨在探讨线性钉钉GJ尺寸对LRYGB长期减重效果的影响。我们对2021年1月至7月间接受LRYGB手术的100例患者进行了回顾性分析。将患者分为两组,每组50名患者,分别为30 mm和45 mm。在术后第15天观察和比较体重减轻情况,并在术后第1、3、6、9、12、18和24个月进行随访。24个月后,30毫米组的BMI平均下降了19.23,而45毫米组的BMI平均下降了16.43 kg/m2
{"title":"The tighter the stoma, the greater the loss: A narrower gastrojejunostomy is more beneficial for weight loss following roux-en-Y gastric bypass","authors":"Keivan Kalali,&nbsp;Tooraj Zandbaf,&nbsp;Ali Esparham,&nbsp;Soheil Ahmadyar,&nbsp;Ali Jangjoo,&nbsp;Mojtaba Meshkat,&nbsp;Mohammad Ebrahim Kalantari,&nbsp;Mohammad Javad Ghamari,&nbsp;Alireza Rezapanah,&nbsp;Amin Dalili","doi":"10.1111/cob.70013","DOIUrl":"10.1111/cob.70013","url":null,"abstract":"<div>\u0000 \u0000 <p>The optimal size of Gastrojejunostomy (GJ) in Laparoscopic Roux-EnY Gastric Bypass (LRYGB) for a- preferential weight loss is still unknown. This study aimed to investigate the influence of linear-stapled GJ size in long-term LRYGB weight reduction results. We performed a retrospective analysis of 100 patients who underwent LRYGB surgery between January and July 2021. The patients were divided into two 50-patient groups based on the size of their linear-stapled GJ, either 30 or 45 mm. Their weight loss was observed and compared on day 15, and the following appointments were 1, 3, 6, 9, 12, 18, and 24 months after surgery. After 24 months, the 30-mm group reduced their BMI by an average of 19.23, compared with the 16.43 kg/m<sup>2</sup> of the 45-mm group (<i>p</i> &lt; .001). Overall, repeated measures ANOVA showed a beneficial weight loss pattern for the 30-mm group in all four categories (weight, BMI, EWL, and TWL). Upon adjusting for age, biliopancreatic length, alimentary length, sex, history of diabetes, and a history of hypertension in repeated measures ANOVA, this difference remained significantly in favour of the 30-mm GJ. Based on the results of this study, performing a gastrojejunostomy with a 30-mm stapler compared to a 45-mm stapler increases weight loss in LRYGB patients.</p>\u0000 </div>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 4","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing risk factors and reoperation rates for laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass 比较腹腔镜袖式胃切除术与Roux-en-Y胃旁路术的危险因素及再手术率。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-18 DOI: 10.1111/cob.70023
Jana K. Elsawwah, Christina T. Nici, Ashish Padnani, Rolando H. Rolandelli, Zoltan H. Nemeth

Obesity has become a growing concern globally as a leading risk factor for several chronic diseases such as diabetes, hypertension, cardiovascular disease and more. Many patients with obesity undergo metabolic and bariatric surgery (MBS) to lose weight and improve their comorbid conditions. Despite the generally accepted efficacy of these operations, some patients will not achieve substantial and sustained weight loss or will experience significant postoperative complications, leading to reoperation within 30 days after the first procedure. Using the 2022 American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database, we selected patients who underwent either a laparoscopic sleeve gastrectomy (LSG) or a laparoscopic Roux-en-Y gastric bypass (LRYGB). Furthermore, we divided patients in each operation cohort into those who underwent reoperation within 30 days and those who did not. Patients who underwent a laparoscopic Roux-en-Y bypass experienced higher rates of reoperation (1.84%) compared to those undergoing an LSG (0.65%). In reoperation groups within both cohorts, comorbidities that commonly impact patients with obesity, such as diabetes, sleep apnoea and gastroesophageal reflux disease, were associated with higher rates of reoperation. As the prevalence of obesity increases worldwide, it is vital to understand the risk factors and complications associated with different types of MBS. Physicians choosing to utilise an LRYGB procedure over an LSG should do so while carefully considering the increased risk of reoperation.

肥胖作为糖尿病、高血压、心血管疾病等多种慢性疾病的主要危险因素,已成为全球日益关注的问题。许多肥胖患者接受代谢和减肥手术(MBS)来减轻体重并改善其合并症。尽管这些手术的疗效被普遍接受,但一些患者不会实现实质性和持续的体重减轻或会出现明显的术后并发症,导致在第一次手术后30天内再次手术。使用2022年美国外科医师学会代谢和减肥手术认证和质量改进计划数据库,我们选择了接受腹腔镜袖式胃切除术(LSG)或腹腔镜Roux-en-Y胃旁路术(LRYGB)的患者。此外,我们将每个手术队列的患者分为30天内再次手术的患者和未再次手术的患者。接受腹腔镜Roux-en-Y旁路手术的患者再手术率(1.84%)高于接受LSG手术的患者(0.65%)。在两个队列中的再手术组中,通常影响肥胖患者的合并症,如糖尿病、睡眠呼吸暂停和胃食管反流病,与更高的再手术率相关。随着全球肥胖患病率的增加,了解与不同类型的MBS相关的危险因素和并发症是至关重要的。医生在选择LRYGB手术而不是LSG手术时,应仔细考虑再手术风险的增加。
{"title":"Comparing risk factors and reoperation rates for laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass","authors":"Jana K. Elsawwah,&nbsp;Christina T. Nici,&nbsp;Ashish Padnani,&nbsp;Rolando H. Rolandelli,&nbsp;Zoltan H. Nemeth","doi":"10.1111/cob.70023","DOIUrl":"10.1111/cob.70023","url":null,"abstract":"<div>\u0000 \u0000 <p>Obesity has become a growing concern globally as a leading risk factor for several chronic diseases such as diabetes, hypertension, cardiovascular disease and more. Many patients with obesity undergo metabolic and bariatric surgery (MBS) to lose weight and improve their comorbid conditions. Despite the generally accepted efficacy of these operations, some patients will not achieve substantial and sustained weight loss or will experience significant postoperative complications, leading to reoperation within 30 days after the first procedure. Using the 2022 American College of Surgeons Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database, we selected patients who underwent either a laparoscopic sleeve gastrectomy (LSG) or a laparoscopic Roux-en-Y gastric bypass (LRYGB). Furthermore, we divided patients in each operation cohort into those who underwent reoperation within 30 days and those who did not. Patients who underwent a laparoscopic Roux-en-Y bypass experienced higher rates of reoperation (1.84%) compared to those undergoing an LSG (0.65%). In reoperation groups within both cohorts, comorbidities that commonly impact patients with obesity, such as diabetes, sleep apnoea and gastroesophageal reflux disease, were associated with higher rates of reoperation. As the prevalence of obesity increases worldwide, it is vital to understand the risk factors and complications associated with different types of MBS. Physicians choosing to utilise an LRYGB procedure over an LSG should do so while carefully considering the increased risk of reoperation.</p>\u0000 </div>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144093099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ethnic differences in weight loss during a clinical obesity management program 临床肥胖管理项目中体重减轻的种族差异。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-11 DOI: 10.1111/cob.70022
Jennifer Linchee Kuk, Parmis Mirzadeh, Sean Wharton

To examine ethnic differences in how individuals respond to obesity management therapies, a retrospective chart review of the Wharton Medical Weight Management Clinic electronic medical records was used (n = 21 709; 14 695 patients with weight loss data). South and East Asian, Middle Eastern and Other ethnicities had a significantly lower body mass index (BMI) at enrollment than White adults (39.7 vs. 35.4–38.7 kg/m2), with higher or similar BMIs in Indigenous and Black adults (39.9–42.2 kg/m2). Whites, East Asians and Other Ethnicities had the greatest weight loss (4.3–4.9 kg), while Blacks (3.3 kg), Latin (3.0 kg), Middle Eastern (2.7 kg), and South Asians (3.5 kg) lost significantly less weight as compared to Whites (4.9 kg) (p < .05). There were also weight loss differences between Black sub-groups. African American females lost the least weight (1.4 kg), while West Indian Black females lost much more weight (4.3 kg, p = .01). African American males also lost the least amount of weight (0.9 kg), while African Black males lost the most (7.4 kg, p = 0.01). There are differences in the weight loss achieved during a clinical obesity management program between individuals of various ethnicities.

为了研究个体对肥胖管理疗法反应的种族差异,使用了沃顿医疗体重管理诊所电子病历的回顾性图表回顾(n = 21 709;14695例患者体重减轻数据)。南亚和东亚、中东和其他种族在入组时的体重指数(BMI)明显低于白人成年人(39.7 vs. 35.4-38.7 kg/m2),土著和黑人成年人的BMI更高或相似(39.9-42.2 kg/m2)。白人、东亚人和其他种族的体重下降幅度最大(4.3-4.9公斤),而黑人(3.3公斤)、拉丁人(3.0公斤)、中东人(2.7公斤)和南亚人(3.5公斤)的体重下降幅度明显低于白人(4.9公斤)
{"title":"Ethnic differences in weight loss during a clinical obesity management program","authors":"Jennifer Linchee Kuk,&nbsp;Parmis Mirzadeh,&nbsp;Sean Wharton","doi":"10.1111/cob.70022","DOIUrl":"10.1111/cob.70022","url":null,"abstract":"<p>To examine ethnic differences in how individuals respond to obesity management therapies, a retrospective chart review of the Wharton Medical Weight Management Clinic electronic medical records was used (<i>n</i> = 21 709; 14 695 patients with weight loss data). South and East Asian, Middle Eastern and Other ethnicities had a significantly lower body mass index (BMI) at enrollment than White adults (39.7 vs. 35.4–38.7 kg/m<sup>2</sup>), with higher or similar BMIs in Indigenous and Black adults (39.9–42.2 kg/m<sup>2</sup>). Whites, East Asians and Other Ethnicities had the greatest weight loss (4.3–4.9 kg), while Blacks (3.3 kg), Latin (3.0 kg), Middle Eastern (2.7 kg), and South Asians (3.5 kg) lost significantly less weight as compared to Whites (4.9 kg) (<i>p</i> &lt; .05). There were also weight loss differences between Black sub-groups. African American females lost the least weight (1.4 kg), while West Indian Black females lost much more weight (4.3 kg, <i>p</i> = .01). African American males also lost the least amount of weight (0.9 kg), while African Black males lost the most (7.4 kg, <i>p</i> = 0.01). There are differences in the weight loss achieved during a clinical obesity management program between individuals of various ethnicities.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70022","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of maternal body mass index (BMI) and gestational weight gain on offspring's weight and BMI z-scores across the first 8 years of life 母亲体重指数(BMI)和妊娠期体重增加对子代生命前8年体重和BMI z分数的影响
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-05 DOI: 10.1111/cob.70021
Zheng Lu, Iskander L. C. Shadid, Jhill Shah, Vincent J. Carey, Nancy Laranjo, George T. O'Connor, Robert S. Zeiger, Leonard Bacharier, Augusto A. Litonjua, Scott T. Weiss, Hooman Mirzakhani

While prior studies have linked maternal pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) to birth weight and early childhood obesity, fewer have examined their joint effect on longitudinal growth trajectories, particularly standardized BMI z-scores through school age. We aimed to examine the relationship between maternal pre-pregnancy BMI, GWG and the trajectory of offspring's early-life weight, BMI z-scores and weight percentiles from birth to age 8. Linear mixed models were employed to assess the association between maternal pre-pregnancy BMI, GWG and children's standardized weight-for-age, BMI and length/height-for-age, adjusting for potential confounders. Data were analysed from 806 mother–child pairs from the Vitamin D Antenatal Asthma Reduction Trial, with children followed longitudinally from birth through 8 years of age. Our study demonstrated a significant association between maternal pre-pregnancy BMI and offspring weight-for-age and BMI z-score trajectories (β = .03, 95% confidence interval [CI]: 0.02–0.04 for both; p < .001, respectively). Specifically, children born to mothers with pre-pregnancy BMI of 25–30 kg/m2 or ≥30 kg/m2 had significantly higher BMI z-scores (β = .15, 95% CI: 0.02–0.29; p = .03; β = .49, 95% CI: 0.33–0.64; p < .001, respectively) compared to those with normal BMI. Maternal BMI was not significantly associated with the child's length/height. GWG was independently and positively associated with weight-for-age and BMI z-scores (β = .01, 95% CI: 0.002–0.015, p = .01 and β = .01, 95% CI: 0.01–0.02, p < .001, respectively). Excessive GWG was linked to higher offspring weight-for-age and BMI z-scores from birth to 8 years (β = .20, 95% CI: 0.08–0.32; β = .19, 95% CI: 0.08–0.31; p = .001, respectively) compared to guideline-congruent or inadequate GWG. Achieving or maintaining a healthy BMI prior to pregnancy and adhering to GWG guidelines may help mitigate the risk of early childhood overweight or obesity.

虽然之前的研究已经将母亲孕前体重指数(BMI)和妊娠期体重增加(GWG)与出生体重和儿童早期肥胖联系起来,但很少有人研究它们对纵向生长轨迹的共同影响,特别是在学龄期的标准化BMI z分数。我们旨在研究母亲孕前BMI、GWG与子女出生至8岁早期体重、BMI z分数和体重百分位数的变化轨迹之间的关系。采用线性混合模型评估孕妇孕前BMI、GWG与儿童标准化年龄体重、BMI和年龄身高/身高之间的关系,并对潜在的混杂因素进行调整。研究人员分析了来自维生素D产前哮喘减少试验的806对母子的数据,对儿童进行了从出生到8岁的纵向跟踪。我们的研究表明,母亲孕前BMI与后代年龄体重和BMI z-score轨迹之间存在显著关联(β =。03, 95%置信区间[CI]: 0.02-0.04;p 2或≥30 kg/m2的患者BMI z-评分显著升高(β =。15, 95% ci: 0.02-0.29;p = .03;β =。49, 95% ci: 0.33-0.64;p
{"title":"Impact of maternal body mass index (BMI) and gestational weight gain on offspring's weight and BMI z-scores across the first 8 years of life","authors":"Zheng Lu,&nbsp;Iskander L. C. Shadid,&nbsp;Jhill Shah,&nbsp;Vincent J. Carey,&nbsp;Nancy Laranjo,&nbsp;George T. O'Connor,&nbsp;Robert S. Zeiger,&nbsp;Leonard Bacharier,&nbsp;Augusto A. Litonjua,&nbsp;Scott T. Weiss,&nbsp;Hooman Mirzakhani","doi":"10.1111/cob.70021","DOIUrl":"10.1111/cob.70021","url":null,"abstract":"<div>\u0000 \u0000 <p>While prior studies have linked maternal pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) to birth weight and early childhood obesity, fewer have examined their joint effect on longitudinal growth trajectories, particularly standardized BMI <i>z</i>-scores through school age. We aimed to examine the relationship between maternal pre-pregnancy BMI, GWG and the trajectory of offspring's early-life weight, BMI <i>z</i>-scores and weight percentiles from birth to age 8. Linear mixed models were employed to assess the association between maternal pre-pregnancy BMI, GWG and children's standardized weight-for-age, BMI and length/height-for-age, adjusting for potential confounders. Data were analysed from 806 mother–child pairs from the Vitamin D Antenatal Asthma Reduction Trial, with children followed longitudinally from birth through 8 years of age. Our study demonstrated a significant association between maternal pre-pregnancy BMI and offspring weight-for-age and BMI <i>z</i>-score trajectories (<i>β</i> = .03, 95% confidence interval [CI]: 0.02–0.04 for both; <i>p</i> &lt; .001, respectively). Specifically, children born to mothers with pre-pregnancy BMI of 25–30 kg/m<sup>2</sup> or ≥30 kg/m<sup>2</sup> had significantly higher BMI <i>z</i>-scores (<i>β</i> = .15, 95% CI: 0.02–0.29; <i>p</i> = .03; <i>β</i> = .49, 95% CI: 0.33–0.64; <i>p</i> &lt; .001, respectively) compared to those with normal BMI. Maternal BMI was not significantly associated with the child's length/height. GWG was independently and positively associated with weight-for-age and BMI <i>z</i>-scores (<i>β</i> = .01, 95% CI: 0.002–0.015, <i>p</i> = .01 and <i>β</i> = .01, 95% CI: 0.01–0.02, <i>p</i> &lt; .001, respectively). Excessive GWG was linked to higher offspring weight-for-age and BMI <i>z</i>-scores from birth to 8 years (<i>β</i> = .20, 95% CI: 0.08–0.32; <i>β</i> = .19, 95% CI: 0.08–0.31; <i>p</i> = .001, respectively) compared to guideline-congruent or inadequate GWG. Achieving or maintaining a healthy BMI prior to pregnancy and adhering to GWG guidelines may help mitigate the risk of early childhood overweight or obesity.</p>\u0000 </div>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143983746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cognitive dissonance for weight stigma reduction: The development and effect of a counter-attitudinal advocacy intervention 减轻体重病耻感的认知失调:一种反态度倡导干预的发展和效果。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-04 DOI: 10.1111/cob.70024
Vanessa Montemarano, Lamia Firasta, Jason Deska, Stephanie E. Cassin

Weight stigmatization is persistent and pervasive, leading to numerous negative consequences. This study developed a weight stigma reduction intervention rooted in Cognitive Dissonance Theory aimed at reducing stigma towards individuals living in larger bodies. Undergraduate students (N = 325) were randomized to one of three conditions: Cognitive Dissonance (i.e., Written Advocacy or Written + Vocalized Advocacy) or Control. Participants in both Cognitive Dissonance conditions provided a written statement advocating for a proposal benefiting individuals living in larger bodies that would be somewhat costly to participants. Those in the Written + Vocalized Advocacy condition also vocalized their arguments to further enhance dissonance. It was hypothesized that compared to Controls, participants in both Cognitive Dissonance conditions would report reduced weight stigma and greater commitment to a prosocial action, with the strongest effects for the Written + Vocalized Advocacy condition. There was a significant reduction in weight stigma across all conditions, but minimal support for significant differences between conditions. Participants in the Cognitive Dissonance conditions did not commit significantly more hours towards the prosocial action compared to Controls. There was limited support that cognitive dissonance was induced. Future studies should pre-screen participants endorsing stronger weight stigma to help ensure they are advocating for a counter-attitudinal cause.

对体重的污名化是持久而普遍的,会导致许多负面后果。本研究开发了一种基于认知失调理论的减轻体重耻辱感的干预措施,旨在减少对体型较大的个体的耻辱感。本科生(N = 325)被随机分为三组:认知失调组(即书面倡导组或书面+口头倡导组)或对照组。两种认知失调条件下的参与者都提供了一份书面声明,支持一项有利于生活在更大身体中的个体的提议,这对参与者来说有些昂贵。在“书面+发声倡导”的情况下,他们也会发声,以进一步增强不和谐。据推测,与对照组相比,认知失调条件下的参与者会报告体重耻辱减少,对亲社会行动的承诺更大,其中书面+口头倡导条件的影响最大。在所有条件下,体重病耻感都有显著减少,但对条件之间显著差异的支持很少。与对照组相比,认知失调组的参与者在亲社会行为上投入的时间并没有显著增加。认知失调是被诱发的这一观点得到了有限的支持。未来的研究应该预先筛选支持更强烈的体重耻辱的参与者,以帮助确保他们倡导反态度的原因。
{"title":"Cognitive dissonance for weight stigma reduction: The development and effect of a counter-attitudinal advocacy intervention","authors":"Vanessa Montemarano,&nbsp;Lamia Firasta,&nbsp;Jason Deska,&nbsp;Stephanie E. Cassin","doi":"10.1111/cob.70024","DOIUrl":"10.1111/cob.70024","url":null,"abstract":"<p>Weight stigmatization is persistent and pervasive, leading to numerous negative consequences. This study developed a weight stigma reduction intervention rooted in Cognitive Dissonance Theory aimed at reducing stigma towards individuals living in larger bodies. Undergraduate students (<i>N</i> = 325) were randomized to one of three conditions: Cognitive Dissonance (i.e., Written Advocacy or Written + Vocalized Advocacy) or Control. Participants in both Cognitive Dissonance conditions provided a written statement advocating for a proposal benefiting individuals living in larger bodies that would be somewhat costly to participants. Those in the Written + Vocalized Advocacy condition also vocalized their arguments to further enhance dissonance. It was hypothesized that compared to Controls, participants in both Cognitive Dissonance conditions would report reduced weight stigma and greater commitment to a prosocial action, with the strongest effects for the Written + Vocalized Advocacy condition. There was a significant reduction in weight stigma across all conditions, but minimal support for significant differences between conditions. Participants in the Cognitive Dissonance conditions did not commit significantly more hours towards the prosocial action compared to Controls. There was limited support that cognitive dissonance was induced. Future studies should pre-screen participants endorsing stronger weight stigma to help ensure they are advocating for a counter-attitudinal cause.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70024","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143964491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The implementation of a Nationally Enhanced Service incentive for weight management: A longitudinal qualitative study of the perceptions and experiences of UK primary care staff on weight management using normalisation process theory 实施全国强化服务激励体重管理:使用正常化过程理论对英国初级保健人员体重管理的看法和经验进行纵向定性研究。
IF 2.1 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-04-29 DOI: 10.1111/cob.70020
Jack B. Joyce, Anisa Hajizadeh, Rachna Begh, Kate Jolly, Susan A. Jebb, Paul Aveyard

In 2021 a Nationally Enhanced Service (NES) incentive for weight management in primary care was rolled out in England. This paid general practices £11.50 for every eligible referral they made to a weight management programme. We explored primary care staff's perceptions, experiences and attitudes toward the NES by conducting 37 semi-structured interviews with General Practitioners (GPs), administrative staff and nurses preceding the introduction of the NES (May to September 2021) and 1 year later following its introduction (September to December 2022). Data were analysed using normalisation process theory. The NES for weight management solidified the position of staff already supportive of referring patients to weight management programmes. For staff less supportive of weight management services, the dissonance between the perceived lack of benefit of services and making referrals to services was reduced with referrals becoming more habitual. Facilitators to implementation included the presence of a coherent national policy; having a ‘champion’ explain key aspects; and a financial incentive if framed as benefiting the practice at large. Barriers included a perception that primary care has been shouldered with a complex and difficult health crisis; a worry over workload burdens; and inefficient and unclear referral systems. The implementation of the NES was broadly welcomed and accepted by primary care staff. Interviewees expressed concerns around the acceptance of weight management policies in primary care, the provision of training to raise the topic of weight and whether the responsibility of weight management fell with primary care, public health or with the patient.

2021年,英格兰推出了一项全国强化服务(NES),鼓励在初级保健中进行体重管理。该公司向全科医生支付了11.50英镑的费用,他们每推荐一个合格的体重管理项目。我们通过对全科医生(gp)、行政人员和护士进行37次半结构化访谈,探讨了初级保健人员对NES的看法、经验和态度,访谈在引入NES之前(2021年5月至9月)和引入NES一年后(2022年9月至12月)进行。数据分析采用归一化过程理论。体重管理的NES巩固了已经支持将患者转介到体重管理方案的工作人员的地位。对于不太支持体重管理服务的工作人员来说,认为服务缺乏益处与转诊服务之间的不协调现象减少了,因为转诊变得更加习惯。促进执行的因素包括有一项连贯的国家政策;有一个“冠军”来解释关键方面;经济上的激励如果被框定为有利于整个实践。障碍包括一种看法,即初级保健一直肩负着复杂和困难的健康危机;对工作量负担的担忧;以及效率低下和不明确的转诊系统。新方法的实施受到初级保健工作人员的广泛欢迎和接受。受访者对在初级保健中接受体重管理政策、提供培训以提出体重问题以及体重管理的责任是否落在初级保健、公共卫生或患者身上表示关切。
{"title":"The implementation of a Nationally Enhanced Service incentive for weight management: A longitudinal qualitative study of the perceptions and experiences of UK primary care staff on weight management using normalisation process theory","authors":"Jack B. Joyce,&nbsp;Anisa Hajizadeh,&nbsp;Rachna Begh,&nbsp;Kate Jolly,&nbsp;Susan A. Jebb,&nbsp;Paul Aveyard","doi":"10.1111/cob.70020","DOIUrl":"10.1111/cob.70020","url":null,"abstract":"<p>In 2021 a Nationally Enhanced Service (NES) incentive for weight management in primary care was rolled out in England. This paid general practices £11.50 for every eligible referral they made to a weight management programme. We explored primary care staff's perceptions, experiences and attitudes toward the NES by conducting 37 semi-structured interviews with General Practitioners (GPs), administrative staff and nurses preceding the introduction of the NES (May to September 2021) and 1 year later following its introduction (September to December 2022). Data were analysed using normalisation process theory. The NES for weight management solidified the position of staff already supportive of referring patients to weight management programmes. For staff less supportive of weight management services, the dissonance between the perceived lack of benefit of services and making referrals to services was reduced with referrals becoming more habitual. Facilitators to implementation included the presence of a coherent national policy; having a ‘champion’ explain key aspects; and a financial incentive if framed as benefiting the practice at large. Barriers included a perception that primary care has been shouldered with a complex and difficult health crisis; a worry over workload burdens; and inefficient and unclear referral systems. The implementation of the NES was broadly welcomed and accepted by primary care staff. Interviewees expressed concerns around the acceptance of weight management policies in primary care, the provision of training to raise the topic of weight and whether the responsibility of weight management fell with primary care, public health or with the patient.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 5","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70020","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143976819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Making do in the absence of specialist support: Exploring healthcare professionals' views, experiences and behaviours around long-term post-bariatric surgery follow-up care in the United Kingdom 在缺乏专家支持的情况下:探索英国医疗保健专业人员对长期减肥手术后随访护理的看法、经验和行为。
IF 2.2 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-04-29 DOI: 10.1111/cob.70016
Ross Watkins, Laura L. Jones, Kenneth Clare, Karen D. Coulman, Colin J. Greaves, Kate Jolly, Emma Shuttlewood, Helen M. Parretti

Bariatric surgery is an effective treatment for obesity, but long-term can lead to health-related issues. Guidelines highlight the importance of long-term post-bariatric surgery follow-up. However, in the UK, there is currently no specific funding to support the delivery of this care. Our aim was to understand the views and experiences of healthcare professionals (HCPs) around long-term post-bariatric surgery follow-up, and barriers and enablers to care. Semi-structured interviews with HCPs in UK primary care or specialist weight management services were conducted. The topic guide was theoretically informed by the Capability-Opportunity-Motivation-Behaviour model and the Theoretical Domains Framework. Thematic analysis was undertaken. Twenty-six HCPs were interviewed. Three core themes were interpreted: Existing Challenges, Mediating Factors and Future Directions. While there was agreement on the need for long-term support, current provision was variable and hampered by a paucity of referral options. Follow-up care could be contingent upon the patients' surgical pathway and the culture and expertise within the general practitioner surgery. Participants discussed potential ways to improve care, including using technology, adapting approaches used in other chronic conditions, shared care models and harnessing the potential for peer-based support to improve wellbeing and quality of life. Healthcare professionals' views and experiences shared in this study highlight the complex issues associated with long-term bariatric surgery follow-up. The findings will inform future research to design and implement care pathways that are urgently needed to improve service provision for these patients.

减肥手术是治疗肥胖的有效方法,但长期可能导致健康问题。指南强调了减肥手术后长期随访的重要性。然而,在英国,目前没有专门的资金来支持这种护理的提供。我们的目的是了解医疗保健专业人员(HCPs)对长期减肥手术后随访的看法和经验,以及护理的障碍和促进因素。对英国初级保健或专业体重管理服务的hcp进行了半结构化访谈。主题指南的理论依据是能力-机会-动机-行为模型和理论领域框架。进行了专题分析。采访了26名医护人员。阐释了三个核心主题:现有挑战、中介因素和未来方向。虽然大家都同意需要长期支助,但目前的提供是不稳定的,而且由于缺乏转诊选择而受到阻碍。后续护理可能取决于患者的手术途径和文化和全科医生的专业知识。与会者讨论了改善护理的潜在方法,包括利用技术、调整其他慢性病的治疗方法、共享护理模式以及利用基于同伴的支持的潜力来改善福祉和生活质量。医疗保健专业人员在本研究中分享的观点和经验强调了与长期减肥手术随访相关的复杂问题。这些发现将为未来的研究提供信息,以设计和实施迫切需要的护理途径,以改善对这些患者的服务提供。
{"title":"Making do in the absence of specialist support: Exploring healthcare professionals' views, experiences and behaviours around long-term post-bariatric surgery follow-up care in the United Kingdom","authors":"Ross Watkins,&nbsp;Laura L. Jones,&nbsp;Kenneth Clare,&nbsp;Karen D. Coulman,&nbsp;Colin J. Greaves,&nbsp;Kate Jolly,&nbsp;Emma Shuttlewood,&nbsp;Helen M. Parretti","doi":"10.1111/cob.70016","DOIUrl":"10.1111/cob.70016","url":null,"abstract":"<p>Bariatric surgery is an effective treatment for obesity, but long-term can lead to health-related issues. Guidelines highlight the importance of long-term post-bariatric surgery follow-up. However, in the UK, there is currently no specific funding to support the delivery of this care. Our aim was to understand the views and experiences of healthcare professionals (HCPs) around long-term post-bariatric surgery follow-up, and barriers and enablers to care. Semi-structured interviews with HCPs in UK primary care or specialist weight management services were conducted. The topic guide was theoretically informed by the Capability-Opportunity-Motivation-Behaviour model and the Theoretical Domains Framework. Thematic analysis was undertaken. Twenty-six HCPs were interviewed. Three core themes were interpreted: <i>Existing Challenges</i>, <i>Mediating Factors</i> and <i>Future Directions</i>. While there was agreement on the need for long-term support, current provision was variable and hampered by a paucity of referral options. Follow-up care could be contingent upon the patients' surgical pathway and the culture and expertise within the general practitioner surgery. Participants discussed potential ways to improve care, including using technology, adapting approaches used in other chronic conditions, shared care models and harnessing the potential for peer-based support to improve wellbeing and quality of life. Healthcare professionals' views and experiences shared in this study highlight the complex issues associated with long-term bariatric surgery follow-up. The findings will inform future research to design and implement care pathways that are urgently needed to improve service provision for these patients.</p>","PeriodicalId":10399,"journal":{"name":"Clinical Obesity","volume":"15 4","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cob.70016","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143981359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Obesity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1